Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Seminars in Arthritis and Rheumatism|July 5, 2022
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosageAnastasios Karamanakos, Maria Tektonidou, Olga Vougiouka, et al.
Mediterranean Journal of Rheumatology|November 16, 2020
Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 PandemicGeorge E Fragoulis, Gerasimos Evangelatos, Aikaterini Arida, et al.
Rheumatology International|November 5, 2021
COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional studyGeorge E Fragoulis, Vassiliki-Kalliopi Bournia, Eugenia Mavrea, et al.
Rheumatology (Oxford, England)|August 7, 2024
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective studyChrysoula G Gialouri, Aglaia Chalkia, Christos Koutsianas, et al.
Rheumatology International|January 3, 2025
Similar Hepatitis B virus reactivation risk for patients with inflammatory arthritis or connective tissue diseases: a multicenter retrospective studyMaria Pappa, Alexandra Koutsogianni, Anastasios Karamanakos, et al.
Rheumatology International|March 4, 2021
Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional studyGeorge E Fragoulis, Ioannis Grigoropoulos, Evgenia Mavrea, et al.
Annals of the Rheumatic Diseases|November 11, 2021
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseasesCharalampos Papagoras, George E Fragoulis, Nikoleta Zioga, et al.
Clinical Rheumatology|September 21, 2023
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseasesCharalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
Seminars in Arthritis and Rheumatism|February 2, 2025
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registryCharalampos Papagoras, George E Fragoulis, Nikolaos Fytanidis, et al.
Frontiers in Medicine|September 19, 2025
Development and implementation of the International AIDA Network Castleman's disease registryAntonio Vitale, Jessica Sbalchiero, Valeria Caggiano, et al.
Pageof 5